Fosun's Kinzon Capital subsidiary has co-led the series A round closed by facial recognition technology developer Shenxing Tech.

Pain management drug developer SiteOne Therapeutics has secured Amgen as a research and development partner and lead investor in its series B round.

The Autodesk-backed series B-1 round will support preparations for a space launch later this year, which could represent the first moon landing by a private company.

Takeda has taken part in a series B round for therapeutic antibody developer Maverick Therapeutics as part of a collaboration deal sized at up to $125m in total.

The crop protection technology developer has added series B funding from backers including Syngenta and Alexandria Real Estate Equities to the $10m it raised in 2014.

Bertelsmann Asia Investments has led a series B round for Nongfenqi, operator of a platform that offers financing to the Chinese agricultural industry.

The voice analysis software producer has added $4.1m to the $15m it raised in November from backers including Salesforce Ventures.

Precision medicine company Avidity Biosciences has received $10m in equity funding and $6m in converted debt from backers including Takeda and EMS.

The Ascenta Therapeutics spinout has completed a series B round that will go to developing its pipeline of small-molecule treatments for cancer, hepatitis B and age-related diseases.

Existing investor Novo has taken part in a $28m round for Nerre Therapeutics, a GlaxoSmithKline spinout focusing on neuronal hypersensitivity treatments.